Clinical outcomes and adverse events of nontuberculous mycobacterial lung disease treated at an Italian tertiary referral center

Treatment of NTM lung disease (NTM-LD) is based on combinations of antimycobacterial drugs. It lasts 12 months if respiratory samples become culture negative, while in refractory cases it can last up to 18–24 months. Therapeutic pathway is complicated by frequent adverse events (AEs). Sometimes, sym...

Ausführliche Beschreibung